| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |